A lecturer in Pharmacology with 12 years of practical experience in intellectual property (IP) law practice through my position as a senior pharmaceutical patent examiner in the Egyptian Patent Office. I’ve got my Ph.D. & Master's in Pharmacology and Toxicology as well as my bachelor's from the Faculty of Pharmacy Cairo University & my Master's in IP Law from Turin University. She established the first IP curriculum for pharmacy students in Egypt among the postgrad programmes. She drafted the IP policy of The British University in Egypt through my role as an IP consultant at the BUE. I delivered several international training programs in many countries, Korea; Kuwait; Tunisia; Arab States of Emirates, in addition to Egypt. She is a certified trainer for IP in the World Intellectual Property Organisation (WIPO) for Arabic- & English-speaking countries; and a certified IP expert from the League of Arab States, as well as a certified trainer in Van Holland University for soft skills and human development programs. She participated in many online courses as a tutor for the European Patent Academy, National IP Academy of Egypt, and as a tutor for delivering the “Patent Drafting Course” on the WIPO Academy platform. She graduated from the copyright program, “CopyrightX” and am a student in the “PatentX program” at Harvard University. I’ve several research papers in the pharmaceutical as well as the IP field and I participated in several national & international pharmaceutical conferences with posters or oral talks about IP and pharmaceutical sciences.

Santosh Tata is a biomedical researcher with extensive experience in animal and plant cell signaling and immunology research. His background in in-vivo and in-vitro experimentation, molecular cloning, microscopy and genomics and protein biochemistry informs his special interest in biomedical research. He considers himself a "forever student" eager to build on his academic foundations in cell and molecular biology, immunology and structural biology and stays in tune with the latest neurobiology and regenerative research through continued learning. Santosh's hunger for knowledge and determination to transform research into action has contributed to his most recent success at Prof Helen Irving's lab at La Trobe University, where he published several articles and delivered award-winning oral presentations at several national and international conferences, such as Bendigo RFA forum, COMBIO, LIMS EMCR. Meanwhile, he vastly improved the research methodologies of his team by implementing strategic experiment management methods and ensuring a work-life balance for his department. Santosh believes mindfulness in the workplace is key to success—a tenet he lives out through his interests in cricket, meditation, and cooking. Santosh is currently working as a casual academic and is always interested in learning new skills.

Yi Fu is an Associate Professor and PI at the Biomedical Sciences College, Shandong First Medical University. She also serves as the Director of the Basic Disease Sciences Teaching and Research Office, a Master’s Supervisor, and a Postdoctoral Cooperative Supervisor. Her research focuses on the pathogenesis and novel therapeutic strategies for metabolic kidney diseases, particularly diabetic nephropathy. Her work explores podocyte lipid metabolic reprogramming mechanisms, the development of interventions for renal metabolic homeostasis, and the design of targeted nanodrug delivery systems for kidney injury. She has led several key research projects, including those supported by the Taishan Scholar Young Expert Program and the National Natural Science Foundation of China. As a first or corresponding author, she has published research in international journals such as Cell Metabolism, Advanced Materials, and Hypertension. Dr. Fu holds multiple academic appointments, including Standing Director of the Shandong Rare Disease Prevention and Treatment Association, Director of the Shandong Pharmacological Society, and Committee Member of the Microecology Professional Committee of the Shandong Biomedical Engineering Society.

Flaviano Lorenzon, PhD, is a physiologist with expertise in human physiology and smooth muscle pharmacology. His research focuses on the functional and biochemical mechanisms regulating visceral and vascular smooth muscle tone, with particular emphasis on nitrergic signaling pathways and novel endogenous modulators. Dr. Lorenzon has extensive experience in ex vivo organ bath studies, isolated tissue preparations, and pharmacodynamic characterization of bioactive compounds. His work investigates the role of nitric oxide–related molecules, including emerging mediators such as 6-nitrodopamine, in the regulation of gastrointestinal and urogenital smooth muscle function. He is particularly interested in translational physiology, aiming to bridge fundamental mechanistic discoveries with potential therapeutic applications in disorders involving smooth muscle dysfunction.

Dr. Iris Lim is a biomedical scientist and an award-winning educator at Bond University, Australia, where she serves as Assistant Dean (Learning & Teaching) in the Faculty of Health Sciences and Medicine. Her laboratory research focuses on the physiology and pharmacology of the urinary tract, particularly the ureter and urethra, with additional work examining the bladder. Alongside her basic science research, Iris is a national and international leader in education and student engagement research, especially the design of educational escape rooms. Iris has received multiple prestigious teaching awards including a National Citation for Outstanding Contributions to Student Learning. She is passionate about empowering learners through creativity, collaboration, and evidence-based education.

Dr. Adisti Dwijayanti, MBiomed, is an academic and researcher at the Faculty of Medicine, Universitas Indonesia. She is a medical doctor who continued her master’s and doctoral degrees in Biomedicine. Her work focuses on pharmacology, herbal medicine, regenerative medicine, and aging. Her current research project focuses on natural extracts for disease prevention, anti-cancer applications, and the exploration of organoids as drug/herbal screening and testing tools.